These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7615203)

  • 1. Association between low-grade disseminated intravascular coagulation and endotoxemia in patients with liver cirrhosis.
    Violi F; Ferro D; Basili S; Saliola M; Quintarelli C; Alessandri C; Cordova C
    Gastroenterology; 1995 Aug; 109(2):531-9. PubMed ID: 7615203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic clotting activation by low-grade endotoxaemia in liver cirrhosis: a potential role for endothelial procoagulant activation.
    Ferro D; Basili S; Lattuada A; Mantovani B; Bellomo A; Mannucci PM; Violi F
    Ital J Gastroenterol Hepatol; 1997 Oct; 29(5):434-40. PubMed ID: 9494853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrinopeptide A in liver cirrhosis: evidence against a major contribution of disseminated intravascular coagulation to coagulopathy of chronic liver disease.
    Mombelli G; Fiori G; Monotti R; Haeberli A; Straub PW
    J Lab Clin Med; 1993 Jan; 121(1):83-90. PubMed ID: 8426084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disseminated intravascular coagulation in liver cirrhosis: fact or fiction?
    Ben-Ari Z; Osman E; Hutton RA; Burroughs AK
    Am J Gastroenterol; 1999 Oct; 94(10):2977-82. PubMed ID: 10520855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperfibrinolysis in liver disease.
    Ferro D; Celestini A; Violi F
    Clin Liver Dis; 2009 Feb; 13(1):21-31. PubMed ID: 19150306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Disseminated intravascular clotting in liver cirrhosis].
    Krug H; Dziewolska M; Sidor H; Gluszek J
    Pol Arch Med Wewn; 1973 Mar; 50(3):243-9. PubMed ID: 4692441
    [No Abstract]   [Full Text] [Related]  

  • 7. Enhanced expression of monocyte tissue factor in patients with liver cirrhosis.
    Saliola M; Lorenzet R; Ferro D; Basili S; Caroselli C; Santo AD; Sallese M; Violi F
    Gut; 1998 Sep; 43(3):428-32. PubMed ID: 9863491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperfibrinolysis resulting from clotting activation in patients with different degrees of cirrhosis. The CALC Group. Coagulation Abnormalities in Liver Cirrhosis.
    Violi F; Ferro D; Basili S; Quintarelli C; Musca A; Cordova C; Balsano F
    Hepatology; 1993 Jan; 17(1):78-83. PubMed ID: 8423044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ongoing prothrombotic state in the portal circulation of cirrhotic patients.
    Violi F; Ferro D; Basili S; Lionetti R; Rossi E; Merli M; Riggio O; Bezzi M; Capocaccia L
    Thromb Haemost; 1997 Jan; 77(1):44-7. PubMed ID: 9031447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disseminated intravascular coagulation with increased fibrinolysis during the early phase of isolated traumatic brain injury.
    Wada T; Gando S; Maekaw K; Katabami K; Sageshima H; Hayakawa M; Sawamura A
    Crit Care; 2017 Aug; 21(1):219. PubMed ID: 28826407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disseminated intravascular coagulation in cirrhosis.
    Carr JM
    Hepatology; 1989 Jul; 10(1):103-10. PubMed ID: 2661390
    [No Abstract]   [Full Text] [Related]  

  • 12. [Determination of plasma level of platelet activating factor in cirrhotic patients and its relation to endotoxemia].
    Zeng N
    Zhonghua Yi Xue Za Zhi; 1992 Mar; 72(3):141-3, 189. PubMed ID: 1319804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin E reduces monocyte tissue factor expression in cirrhotic patients.
    Ferro D; Basili S; Praticó D; Iuliano L; FitzGerald GA; Violi F
    Blood; 1999 May; 93(9):2945-50. PubMed ID: 10216089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clotting activation and hyperfibrinolysis in cirrhosis: implication for bleeding and thrombosis.
    Violi F; Ferro D
    Semin Thromb Hemost; 2013 Jun; 39(4):426-33. PubMed ID: 23487343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coagulofibrinolytic changes in patients with disseminated intravascular coagulation associated with post-cardiac arrest syndrome--fibrinolytic shutdown and insufficient activation of fibrinolysis lead to organ dysfunction.
    Wada T; Gando S; Mizugaki A; Yanagida Y; Jesmin S; Yokota H; Ieko M
    Thromb Res; 2013 Jul; 132(1):e64-9. PubMed ID: 23726093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High plasma levels of von Willebrand factor as a marker of endothelial perturbation in cirrhosis: relationship to endotoxemia.
    Ferro D; Quintarelli C; Lattuada A; Leo R; Alessandroni M; Mannucci PM; Violi F
    Hepatology; 1996 Jun; 23(6):1377-83. PubMed ID: 8675154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of several parameters of coagulation in liver cirrhosis: disseminated intravascular coagulation or pseudo-disseminated intravascular coagulation?].
    Petrella V; Parachini F; Rigotti T; Galimberti M; Cusumano S
    Minerva Med; 1988 Mar; 79(3):193-8. PubMed ID: 3362400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concentration of prothrombin fragment 1 + 2 (f1 + 2) in patients with liver cirrhosis and chronic hepatitis C infection.
    Fota-Markowska H; Modrzewska R; Krzowska-Firych J; Lis-Tønder J; Borowicz I
    Ann Univ Mariae Curie Sklodowska Med; 2004; 59(2):4-7. PubMed ID: 16146040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of liver cirrhosis complicated with endotoxemia and disseminated intravascular coagulation: a case report.
    Yajima Y; Otsuki M; Suzuki H; Mori K; Goto Y
    Tohoku J Exp Med; 1987 Mar; 151(3):269-74. PubMed ID: 3109073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ascites fluid as a possible origin for hyperfibrinolysis in advanced liver disease.
    Agarwal S; Joyner KA; Swaim MW
    Am J Gastroenterol; 2000 Nov; 95(11):3218-24. PubMed ID: 11095345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.